↓ Skip to main content

Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema

Overview of attention for article published in Cochrane database of systematic reviews, October 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (64th percentile)

Mentioned by

twitter
6 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
36 Dimensions

Readers on

mendeley
128 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema
Published in
Cochrane database of systematic reviews, October 2019
DOI 10.1002/14651858.cd002312.pub4
Pubmed ID
Authors

Emile S Altmann, Iain Crossingham, Stephen Wilson, Huw R Davies

Twitter Demographics

The data shown below were collected from the profiles of 6 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 128 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 128 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 20 16%
Student > Master 16 13%
Researcher 12 9%
Student > Doctoral Student 11 9%
Other 9 7%
Other 18 14%
Unknown 42 33%
Readers by discipline Count As %
Medicine and Dentistry 45 35%
Nursing and Health Professions 7 5%
Pharmacology, Toxicology and Pharmaceutical Science 7 5%
Psychology 5 4%
Neuroscience 2 2%
Other 10 8%
Unknown 52 41%

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 September 2022.
All research outputs
#6,033,509
of 22,143,852 outputs
Outputs from Cochrane database of systematic reviews
#7,910
of 12,195 outputs
Outputs of similar age
#122,496
of 353,025 outputs
Outputs of similar age from Cochrane database of systematic reviews
#23
of 24 outputs
Altmetric has tracked 22,143,852 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 12,195 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.9. This one is in the 34th percentile – i.e., 34% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 353,025 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one is in the 8th percentile – i.e., 8% of its contemporaries scored the same or lower than it.